Advances in early stage ovarian cancer diagnosis
30 November, 2007HealthLinx has reached an agreement with The University of Liverpool (UK) to in-license patented biomarkers and antibodies that show efficacy in detecting grade one and two ovarian cancer.
Alzheimer's vaccine gets European patent
29 November, 2007The Vienna-based company, Affiris, announced that it has been granted a Europe-wide patent for a pool of peptide sequences that are key elements of its Alzheimer’s vaccine. The company will be able to use these newly patented components to manufacture an optimised vaccine against beta-amyloid, the peptide responsible for the onset of Alzheimer’s disease.
A guide to inhibit measles infection
26 November, 2007Infecting almost 20 million people worldwide each year, the measles virus remains a dangerous, highly contagious disease despite extensive vaccination efforts. However, recent advancements in understanding the pathogen’s binding mechanism could provide a new strategy to fight infection.
Childhood leukaemia researcher wins award
26 November, 2007Petra Bachmann was announced this year’s Open Senior Division winner in the highly respected Coast Association Tow Research Awards.
Cancer-causing protein pathway identified
19 November, 2007Researchers have discovered a protein pathway that causes two common forms of cancer, neuroblastoma (the most common tumour of infants) and breast cancer.
Scientists find genetic key to autoimmune diseases
08 November, 2007The discovery of how the gene Roquin suppresses autoimmune diseases like Type 1 diabetes and lupus could open the way for improved treatments for such conditions, scientists propose.
Research finds cancer drug susceptibility gene
07 November, 2007Researchers have identified a cancer-prevention gene that influences the success of drug treatment for childhood cancer.
Scientists find markers for testicular cancer
02 November, 2007Scientists in the Netherlands have made significant advances in testicular cancer research, by identifying and analysing a set of specific microRNA molecular markers that are involved in the development of testicular tumours.
Exploring ‘bench to bedside’ investment opportunities
25 October, 2007The Health Partnerships for the Future event, hosted by UQ’s Faculty of Health Sciences, will be held on Tuesday 30 October at Brisbane Customs House.
Volunteers sought for study
11 October, 2007Nobel Laureate Professor Barry Marshall is seeking volunteers to take part in a potentially ground-breaking study.
Biosensor detects avian influenza virus in minutes
05 October, 2007Quick identification of avian influenza infection in poultry is critical to controlling outbreaks, but current detection methods can require several days to produce results
A faster prenatal test for Down syndrome
20 September, 2007Scientists in California have advanced toward rapid testing for pre-natal detection of Down syndrome and other birth defects involving an abnormal number of chromosomes.
A patient database to boost Parkinson's research
17 September, 2007The Howard Florey Institute and Parkinson's Victoria have teamed up to establish the Parkinson’s Victoria Research Register (PVRR) — a living patient database for Parkinson's disease (PD), the nation’s second most common, chronic neurological condition.
New approach to fighting obesity and diabetes
11 September, 2007Scientists at the University of Queensland (UQ) are using specially designed equipment to determine how to produce food which is better for us, but still tastes good.
Blood banking test automation
10 September, 2007BioTek Instruments has developed, in partnership with Immucor, an automated benchtop assay instrument for use in the blood transfusion industry. Manufactured by BioTek exclusively for Immucor, the Galileo Echo provides small to medium sized hospital blood bank laboratories with walk-away automation of tests such as ABO grouping and Rh (D) typing, detection/identification of IgG red blood cell antibodies, compatibility testing and red blood cell phenotyping for significant increases in productivity and patient safety while taking less time than other methods.
